Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autologous stem cell transplantations

K Remes, A Rajamäki

    Annals of Medicine
    |April 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    High-dose chemotherapy with autologous stem cell support improves cancer treatment. Mobilizing and transplanting blood-derived stem cells (CD34+ cells) offers faster recovery and lower mortality compared to traditional bone marrow transplants.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

    Leukemia·2016
    Same author

    A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.

    Bone marrow transplantation·2015
    Same author

    Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT.

    Bone marrow transplantation·2015
    Same author

    Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma.

    Bone marrow transplantation·2014
    Same author

    Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.

    Blood cancer journal·2014
    Same author

    Outcome of allogeneic SCT in patients with pre-transplant invasive fungal infection.

    Bone marrow transplantation·2013
    Same journal

    Prevalence and determinants of alcohol use disorder and its association with adherence to antihypertensive therapy among adult hypertensive patients in a hospital setting, Northwest Ethiopia.

    Annals of medicine·2026
    Same journal

    Early detection of severe fetal growth restriction using multimodal deep learning based on ultrasound and prenatal biomarkers.

    Annals of medicine·2026
    Same journal

    Tinnitus, hyperacusis and somatic complaints in a diverse Norwegian clinical population: implications for assessment and rehabilitation.

    Annals of medicine·2026
    Same journal

    Epidemiological analysis of acute poisoning cases based on Poison control center data from 2021 to 2024.

    Annals of medicine·2026
    Same journal

    Pediatric nurses' stress and their knowledge, attitudes, and practices towards first-aid for pediatric trauma: a latent profile analysis.

    Annals of medicine·2026
    Same journal

    Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial.

    Annals of medicine·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Stem Cell Transplantation

    Background:

    • Autologous stem cell transplantation is a key strategy for treating various hematological and non-hematological malignancies.
    • High-dose therapy necessitates effective rescue via stem cell infusion to mitigate severe bone marrow injury.

    Discussion:

    • Stem cells can be sourced from bone marrow or mobilized into the blood for leukapheresis.
    • Mobilization of CD34+ cells from bone marrow to blood is crucial for leukapheresis.
    • Blood-derived stem cells offer advantages over bone marrow, including more rapid hematopoietic recovery post-transplant.

    Key Insights:

    • Rapid hematopoietic recovery following autologous blood stem cell transplantation leads to a shorter cytopenic period.
    • The reduced duration of neutropenia is associated with lower transplantation-related mortality.

    Related Experiment Videos

  • Successful autotransplants depend on adequate stem cell enumeration and collection.

    • Outlook:

    • Future research may focus on optimizing stem cell mobilization and collection techniques.
    • Exploring novel strategies to further enhance hematopoietic recovery and reduce transplant-related complications.
    • Expanding the application of autologous stem cell transplantation to a broader range of cancers.